| Income Statement | 2025-09-26 | 2025-06-27 | 2025-03-28 | 2024-09-27 |
|---|---|---|---|---|
| Net sales | 94,732 | 44,320 | 42,589 | 88,590 |
| Cost of sales | 16,857 | 11,521 | 14,584 | 20,103 |
| Gross profit | 77,875 | 32,799 | 28,005 | 68,487 |
| General and administrative | 20,763 | 20,969 | 24,458 | 21,685 |
| Selling and marketing | 23,461 | 26,283 | 24,621 | 26,623 |
| Research and development | 9,209 | 10,263 | 13,663 | 14,497 |
| Merger costs | 5,926 | - | - | - |
| Restructuring, impairment and related charges | 26 | 5,248 | 22,664 | - |
| Total selling, general and administrative expenses | 59,385 | 62,763 | 85,406 | 62,805 |
| Operating income (loss) | 18,490 | -29,964 | -57,401 | 5,682 |
| Interest income, net | 790 | 1,366 | 1,366 | 1,407 |
| Gain (loss) on foreign currency transactions | -843 | 2,563 | 1,418 | 5,931 |
| Other income, net | 353 | 120 | 131 | 139 |
| Total other income, net | 300 | 4,049 | 2,915 | 7,477 |
| Income (loss) before income taxes | 18,790 | -25,915 | -54,486 | 13,159 |
| Provision for income taxes | 9,906 | -9,103 | -275 | 3,179 |
| Net income (loss) | 8,884 | -16,812 | -54,211 | 9,980 |
| Denominator for basic calculation | 49,633,000 | 49,520,000 | 49,344,000 | 49,199,000 |
| Earnings per share, basic, total | 0.18 | -0.34 | -1.1 | 0.2 |
| Earnings per share, diluted, total | 0.18 | -0.34 | -1.1 | 0.2 |
| Weighted average number of shares outstanding, diluted, total | 50,549,000 | 49,520,000 | 49,344,000 | 49,731,000 |
STAAR SURGICAL CO (STAA)
STAAR SURGICAL CO (STAA)